Skyline Diagnostics developed the AMLprofiler test to identify AML subtypes and support personalized cancer treatment decisions
Skyline Diagnostics developed the AMLprofiler test to identify AML subtypes and support personalized cancer treatment decisions. The company specializes in molecular diagnostics for blood cancers, providing standardized and automated tests for rapid patient classification.